These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 9538248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase unmask transcriptional regulation of hepatic low-density lipoprotein receptor gene expression by dietary cholesterol.
    Lopez D, Ness GC.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):215-9. PubMed ID: 9244400
    [Abstract] [Full Text] [Related]

  • 3. Hypocholesterolemic mechanism of Chlorella: Chlorella and its indigestible fraction enhance hepatic cholesterol catabolism through up-regulation of cholesterol 7alpha-hydroxylase in rats.
    Shibata S, Hayakawa K, Egashira Y, Sanada H.
    Biosci Biotechnol Biochem; 2007 Apr 01; 71(4):916-25. PubMed ID: 17420587
    [Abstract] [Full Text] [Related]

  • 4. Compensatory responses to inhibition of hepatic squalene synthase.
    Lopez D, Chambers CM, Keller RK, Ness GC.
    Arch Biochem Biophys; 1998 Mar 15; 351(2):159-66. PubMed ID: 9514656
    [Abstract] [Full Text] [Related]

  • 5. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
    Mascaró C, Ortiz JA, Ramos MM, Haro D, Hegardt FG.
    Arch Biochem Biophys; 2000 Feb 15; 374(2):286-92. PubMed ID: 10666309
    [Abstract] [Full Text] [Related]

  • 6. Regulation of intracellular cholesterol metabolism.
    Sato R, Takano T.
    Cell Struct Funct; 1995 Dec 15; 20(6):421-7. PubMed ID: 8825062
    [Abstract] [Full Text] [Related]

  • 7. Hepatic farnesyl diphosphate synthase expression is suppressed by polyunsaturated fatty acids.
    Le Jossic-Corcos C, Gonthier C, Zaghini I, Logette E, Shechter I, Bournot P.
    Biochem J; 2005 Feb 01; 385(Pt 3):787-94. PubMed ID: 15473864
    [Abstract] [Full Text] [Related]

  • 8. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.
    Powell EE, Kroon PA.
    J Clin Invest; 1994 May 01; 93(5):2168-74. PubMed ID: 8182149
    [Abstract] [Full Text] [Related]

  • 9. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
    Straka MS, Panini SR.
    Arch Biochem Biophys; 1995 Feb 20; 317(1):235-43. PubMed ID: 7872789
    [Abstract] [Full Text] [Related]

  • 10. LDL receptor gene transcription is selectively induced by t10c12-CLA but not by c9t11-CLA in the human hepatoma cell line HepG2.
    Ringseis R, König B, Leuner B, Schubert S, Nass N, Stangl G, Eder K.
    Biochim Biophys Acta; 2006 Oct 20; 1761(10):1235-43. PubMed ID: 16982210
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A role for smooth endoplasmic reticulum membrane cholesterol ester in determining the intracellular location and regulation of sterol-regulatory-element-binding protein-2.
    Iddon CR, Wilkinson J, Bennett AJ, Bennett J, Salter AM, Higgins JA.
    Biochem J; 2001 Sep 01; 358(Pt 2):415-22. PubMed ID: 11513740
    [Abstract] [Full Text] [Related]

  • 13. Regulatory mechanism of mineral-balanced deep sea water on hypocholesterolemic effects in HepG2 hepatic cells.
    Lee KS, Kwon YS, Kim S, Moon DS, Kim HJ, Nam KS.
    Biomed Pharmacother; 2017 Feb 01; 86():405-413. PubMed ID: 28012395
    [Abstract] [Full Text] [Related]

  • 14. Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6J mice.
    Chung MJ, Sung NJ, Park CS, Kweon DK, Mantovani A, Moon TW, Lee SJ, Park KH.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):159-70. PubMed ID: 17976573
    [Abstract] [Full Text] [Related]

  • 15. Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2.
    König B, Koch A, Spielmann J, Hilgenfeld C, Stangl GI, Eder K.
    Biochem Pharmacol; 2007 Feb 15; 73(4):574-85. PubMed ID: 17126302
    [Abstract] [Full Text] [Related]

  • 16. Effects of LY295427, a low-density lipoprotein (LDL) receptor up-regulator, on LDL receptor gene transcription and cholesterol metabolism in normal and hypercholesterolemic hamsters.
    Bensch WR, Gadski RA, Bean JS, Beavers LS, Schmidt RJ, Perry DN, Murphy AT, McClure DB, Eacho PI, Breau AP, Archer RA, Kauffman RF.
    J Pharmacol Exp Ther; 1999 Apr 15; 289(1):85-92. PubMed ID: 10086991
    [Abstract] [Full Text] [Related]

  • 17. Effect of thyroid hormone on hepatic cholesterol 7 alpha hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA levels in hypophysectomized rats.
    Ness GC, Pendleton LC, Li YC, Chiang JY.
    Biochem Biophys Res Commun; 1990 Nov 15; 172(3):1150-6. PubMed ID: 2123100
    [Abstract] [Full Text] [Related]

  • 18. Modulation of hepatic apolipoprotein B, 3-hydroxy-3-methylglutaryl-CoA reductase and low-density lipoprotein receptor mRNA and plasma lipoprotein concentrations by defined dietary fats. Comparison of trimyristin, tripalmitin, tristearin and triolein.
    Bennett AJ, Billett MA, Salter AM, Mangiapane EH, Bruce JS, Anderton KL, Marenah CB, Lawson N, White DA.
    Biochem J; 1995 Oct 01; 311 ( Pt 1)(Pt 1):167-73. PubMed ID: 7575449
    [Abstract] [Full Text] [Related]

  • 19. A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome.
    Tovar AR, Murguía F, Cruz C, Hernández-Pando R, Aguilar-Salinas CA, Pedraza-Chaverri J, Correa-Rotter R, Torres N.
    J Nutr; 2002 Sep 01; 132(9):2562-9. PubMed ID: 12221209
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.